Immutep raises $68m to fund cancer trials until 2026

SYDNEY: Immutep, an immunotherapy-focused biotech, has raised $68m from institutional investors to fund clinical trials… read more
HealthCo rents safe despite GenesisCare’s US woes

BRISBANE: HealthCo Healthcare & Wellness REIT, an ASX-listed specialty healthcare landlord, is confident it is… read more